b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31605446</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>07</Month>\n            <Day>14</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>07</Month>\n            <Day>14</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1615-9314</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>43</Volume>\n                    <Issue>1</Issue>\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>Jan</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Journal of separation science</Title>\n                <ISOAbbreviation>J Sep Sci</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>High-resolution capillary zone electrophoresis and mass spectrometry for distinction of undersialylated and hypoglycosylated transferrin glycoforms in body fluids.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>241-257</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1002/jssc.201900857</ELocationID>\n            <Abstract>\n                <AbstractText>High-resolution capillary zone electrophoresis is used to distinguish transferrin glycoforms present in human serum, cerebrospinal fluid, and serum treated with neuraminidase and N-glycosidase F. The obtained data are compared to mass spectrometry data from the literature. The main focus is on the analysis of the various asialo-transferrin, monosialo-transferrin, and disialo-transferrin molecules found in these samples. The features of capillary zone electrophoresis and mass spectrometry are reviewed and highlighted in the context of the analysis of undersialylated and hypoglycosylated transferrin molecules. High-resolution capillary zone electrophoresis represents an effective tool to assess the diversity of transferrin patterns whereas mass spectrometry is the method of choice to elucidate structural identification about the glycoforms. Hypoglycosylated transferrin glycoforms present in sera of alcohol abusers and normal subjects are structurally identical to those in sera of patients with a congenital disorder of glycosylation type I. Asialo-transferrin, monosialo-transferrin and disialo-transferrin observed in sera of patients with a type II congenital disorder of glycosylation or a hemolytic uremic syndrome, in cerebrospinal fluid and after treatment of serum with neuraminidase are undersialylated transferrin glycoforms with two N-glycans of varying structure. Undersialylated disialo-transferrin is also observed in sera with high levels of trisialo-transferrin.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 2019 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Caslavska</LastName>\n                    <ForeName>Jitka</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Clinical Pharmacology Laboratory, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Schild</LastName>\n                    <ForeName>Christof</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Institute of Clinical Chemistry, Inselspital, University Hospital and University of Bern, Bern, Switzerland.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Thormann</LastName>\n                    <ForeName>Wolfgang</ForeName>\n                    <Initials>W</Initials>\n                    <Identifier Source="ORCID">https://orcid.org/0000-0002-9762-1609</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Clinical Pharmacology Laboratory, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D016454">Review</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>23</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Germany</Country>\n            <MedlineTA>J Sep Sci</MedlineTA>\n            <NlmUniqueID>101088554</NlmUniqueID>\n            <ISSNLinking>1615-9306</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D014168">Transferrin</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D001826" MajorTopicYN="N">Body Fluids</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019075" MajorTopicYN="N">Electrophoresis, Capillary</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006031" MajorTopicYN="N">Glycosylation</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013058" MajorTopicYN="N">Mass Spectrometry</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014168" MajorTopicYN="N">Transferrin</DescriptorName>\n                <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">asialo-transferrin</Keyword>\n            <Keyword MajorTopicYN="N">capillary electrophoresis</Keyword>\n            <Keyword MajorTopicYN="N">congenital disorder of glycosylation</Keyword>\n            <Keyword MajorTopicYN="N">disialo-transferrin</Keyword>\n            <Keyword MajorTopicYN="N">mass spectrometry</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>08</Month>\n                <Day>20</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>01</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>09</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>13</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>7</Month>\n                <Day>15</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>13</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31605446</ArticleId>\n            <ArticleId IdType="doi">10.1002/jssc.201900857</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Title>REFERENCES</Title>\n            <Reference>\n                <Citation>de Jong, G., van Ejik, H. G., Microheterogeneity of human serum transferrin: A biological phenomenon studied by isoelectric focusing in immobilized pH gradients. Electrophoresis 1988, 9, 589-598.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Arndt, T., Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: A critical review of preanalysis, analysis, and interpretation. Clin. Chem. 2001, 47, 13-27.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Caslavska, J., Thormann, W., Monitoring of alcohol markers by capillary electrophoresis. J. Sep. Sci. 2013, 36, 75-95.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Caslavska, J., Thormann, W., Monitoring of transferrin isoforms in biological samples by capillary electrophoresis. J. Sep. Sci. 2018, 41, 303-322.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Helander, A., Husa, A., Jeppsson, J. O., Improved HPLC method for carbohydrate-deficient transferrin in serum. Clin. Chem. 2003, 49, 1881-1890.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Henry, H., Froehlich, F., Perret, R., Tissot, J.-D., Eilers-Messerli, B., Lavanchy, D., Dionisi-Vici, C., Gonvers, J.-J., Bachmann, C., Microheterogeneity of serum glycoproteins in patients with chronic alcohol abuse compared with carbohydrate-deficient glycoprotein syndrome type I. Clin. Chem. 1999, 45, 1408-1413.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Carchon, H. A., Chevign\xc3\xa9, R., Falmagne, J.-B., Jaeken, J., Diagnosis of congenital disorders of glycosylation by capillary zone electrophoresis of serum transferrin. Clin. Chem. 2004, 50, 101-111.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Marklov\xc3\xa1, E., Albahri, Z., Screening and diagnosis of congenital disorders of glycosylation. Clin. Chim. Acta 2007, 385, 6-20.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Jaeken, J., Congenital disorders of glycosylation. Ann. N.Y. Acad. Sci. 2010, 1214, 190-198.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Wada, Y., Mass spectrometry for congenital disorders of glycosylation, CDG. J. Chromatogr. B 2006, 838, 3-8.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Sturiale, L., Barone, R., Garozzo, D., The impact of mass spectrometry in the diagnosis of congenital disorders of glycosylation. J. Inherit. Metab. Dis. 2011, 34, 891-899.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>van Scherpenzeel, M., Steenbergen, G., Morava, E., Wevers, R. A., Lefeber, D. J., High-resolution mass spectrometry glycoprofiling of intact transferrin for diagnosis and subtype identification in the congenital disorders of glycosylation. Transl. Res. 2015, 166, 639-649.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>G\xc3\xb6rg, A., Weser, J., Westermeier, R., Postel, W., Weidinger, S., Patutschnick, W., Cleve, H., Isoelectric focusing with immobilized pH gradients for the analysis of transferrin (Tf) subtypes and variants. Hum. Genet. 1983, 64, 222-226.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Pascali, V. L., Dobosz, M., Destro-Bisol, G., D\'Aloja E., Characterization of genetic variants of human serum transferrin by isoelectric focusing: Comparison between conventional and immobilized pH gradients, and application to a protocol for paternity testing. Electrophoresis 1988, 9, 411-417.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Crivellente, F., Fracasso, G., Valentini, R., Manetto, G., Riviera, A. P., Tagliaro, F., Improved method for carbohydrate-deficient transferrin determination in human serum by capillary zone electrophoresis. J. Chromatogr. B 2000, 739, 81-93.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Lanz, C., Kuhn, M., Bortolotti, F., Tagliaro, F., Thormann, W., Evaluation and optimization of capillary zone electrophoresis with different dynamic capillary coatings for the determination of carbohydrate-deficient transferrin in human serum. J. Chromatogr. A 2002, 979, 43-57.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Wuyts, B., Delanghe, J. R., Kasvosve, I., Wauters A, Neels H, Janssens J., Determination of carbohydrate-deficient transferrin using capillary zone electrophoresis. Clin. Chem. 2001, 47, 247-255.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Legros, F. J., Nuyens, V., Minet, E., Emonts, P., Zouaoui Boudjeltia, K., Courbe, A., Ruelle, J.-L., Colicis, J., de L\'Escaille, F., Henry, J.-P., Carbohydrate-deficient transferrin isoforms measured by capillary zone electrophoresis for detection of alcohol abuse. Clin. Chem. 2002, 48, 2177-2186.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Lanz, C., Marti, U., Thormann, W., Capillary zone electrophoresis with a dynamic double coating for analysis of carbohydrate-deficient transferrin in human serum. Precision performance and pattern recognition. J. Chromatogr. A 2003, 1013, 131-147.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Joneli, J., Lanz, C., Thormann, W., Capillary zone electrophoresis determination of carbohydrate-deficient transferrin using the new CEofix reagents under high-resolution conditions. J. Chromatogr. A 2006, 1130, 272-280.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Kleinert, P., Kuster, T., Durka, S., Ballhausen, D., Bosshard, N. U., Steinmann, B., H\xc3\xa4nseler, E., Jaeken, J., Heizmann, C. W., Troxler, H., Mass spectrometric analysis of human transferrin in different body fluids. Clin. Chem. Lab. Med. 2003, 41, 1580-1588.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Sanz-Nebot, V., Balaguer, E., Benavente, F., Neus\xc3\xbcss, C., Barbosa, J., Characterization of transferrin glycoforms in human serum by CE-UV and CE-ESI-MS. Electrophoresis 2007, 28, 1949-1957.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Rodr\xc3\xadguez, S. A., Gonz\xc3\xa1lez, E. B., Llamas, G. A., Montes-Bay\xc3\xb3n, M., Sanz-Medel, A., Detection of transferrin isoforms in human serum: Comparison of UV and ICP-MS detection after CZE and HPLC separations. Anal. Bioanal. Chem. 2005, 383, 390-397.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Barroso, A., Gim\xc3\xa9nez, E., Benavente, F., Barbosa, J., Sanz-Nebot, V., Analysis of human transferrin glycopeptides by capillary electrophoresis and capillary liquid chromatography-mass spectrometry. Application to diagnosis of alcohol dependence. Anal. Chim. Acta 2013, 804, 167-175.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Medina-Casanellas, S., Benavente, F., Gim\xc3\xa9nez, E., Barbosa, J., Sanz-Nebot, V., On-line immunoaffinity solid-phase extraction capillary electrophoresis mass spectrometry for the analysis of large biomolecules: A preliminary report. Electrophoresis 2014, 35, 2130-2136.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Kohler, I., Augsburger, M., Serge Rudaz, S., Schappler, J., New insights in carbohydrate-deficient transferrin analysis with capillary electrophoresis-mass spectrometry. Forensic Sci. Int. 2014, 243, 14-22.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Caslavska, J., Lanz, C., Burda, P., Tobler, M., Thormann, W., Analysis of genetic variants of transferrin in human serum after desialylation by capillary zone electrophoresis and capillary isoelectric focusing. J. Sep. Sci. 2017, 40, 2488-2497.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Yang, L., Tang, Q., Harrata, A. K., Lee, C. S., Capillary isoelectric focusing - electrospray ionization mass spectrometry for transferrin glycoforms analysis. Anal. Biochem. 1996, 243, 140-149.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Kuroda, Y., Yukinaga, H., Kitano, M., Noguchi, T., Nemati, M., Shibukawa, A., Nakagawa, T., Matsuzaki, K., On-line capillary isoelectric focusing - mass spectrometry for quantitative analysis of peptides and proteins. J. Pharm. Biomed. Anal. 2005, 37, 423-428.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Delanghe, J. R., Helander, A., Wielders, J. P. M., Pekelharing, J. M., Roth, H. J., Schellenberg, F., Born, C., Yagmur, E., Gentzer, W., Althaus, H., Development and multicenter evaluation of the N latex CDT direct immunonephelometric assay for serum carbohydrate-deficient transferrin. Clin. Chem. 2007, 1115-1121.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Marti, U., Joneli, J., Caslavska, J., Thormann, W., Determination of carbohydrate-deficient transferrin in human serum by two capillary zone electrophoresis methods and a direct immunoassay: Comparison of patient data. J. Sep. Sci. 2008, 31, 3079-3087.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Tobler, M., Caslavska, J., Burda, P., Thormann, W., High-resolution capillary zone electrophoresis for transferrin glycoform analysis associated with congenital disorders of glycosylation. J. Sep. Sci. 2018, 41, 2808-2818.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Caslavska, J., Joneli, J., Wanzenried, U., Schiess, J., Lanz, C., Thormann, W., Determination of genetic transferrin variants in human serum by capillary zone electrophoresis. J. Sep. Sci. 2014, 37, 1663-1670.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Joneli, J., Wanzenried, U., Schiess, J., Lanz, C., Caslavska, J., Thormann, W., Determination of carbohydrate-deficient transferrin in human serum by capillary zone electrophoresis: Evaluation of assay performance and quality assurance over a 10-year period in the routine arena. Electrophoresis 2013, 34, 1563-1571.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Lanz, C., Kuhn, M., Deiss, V., Thormann, W., Improved capillary electrophoresis method for the determination of carbohydrate-deficient transferrin in patient sera. Electrophoresis 2004, 25, 2309-2318.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Lanz, C., Thormann, W., Capillary zone electrophoresis with a dynamic double coating for analysis of carbohydrate-deficient transferrin in human serum: Impact of resolution between disialo- and trisialotransferrin on reference limits. Electrophoresis 2003, 24, 4272-4281.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Lanz, C., Falmagne, J.-B., de l\'Escaille, F., Marti, U., Thormann, W., Determination of carbohydrate-deficient transferrin in human serum with capillary zone electrophoresis. Sample preparation strategies for the removal of interferences caused by increased levels of immunoglobulins. J. Chromatogr. A 2008, 1206, 33-40.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Caslavska, J., Joneli, J., Wanzenried, U., Schiess, J., Thormann, W., Transferrin immunoextraction for determination of carbohydrate-deficient transferrin in human serum by capillary zone electrophoresis. J. Sep. Sci. 2012, 35, 3521-3528.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Lacey, J. M., Bergen, H. R., Magera, M. J., Naylor, S., O\'Brien, J. F., Rapid determination of transferrin isoforms by immunoaffinity liquid chromatography and electrospray mass spectrometry. Clin. Chem. 2001, 47, 513-518.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Guillard, M., Morava, E., van Delft, F. L., Hague, R., K\xc3\xb6rner, C., Adamowicz, M., Wevers, R. A., Lefeber, D. J., Plasm N-glycan profiling by mass spectrometry for congenital disorders of glycosylation type II. Clin. Chem. 2011, 57, 593-602.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Heywood, W. E., Mills, P., Grunewald, S., Worthington, V., Jaeken, J., Carreno, G., Lemonde, H., Clayton, P. T., Mills, K., A new method for the rapid diagnosis of protein N-linked congenital disorders of glycosylation. J. Proteome Res. 2013, 12, 3471-3479.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Wada, Y., Mass spectrometry of transferrin glycoforms to detect congenital disorders of glycosylation: Site-specific profiles and pitfalls. Proteomics 2016, 16, 3105-3110.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>van Scherpenzeel, M., Willems, E., Lefeber, D. J., Clinical diagnostics and therapy monitoring in the congenital disorders of glycosylation. Glycoconj. J. 2016, 33, 345-358.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Barroso, A., Gim\xc3\xa9nez, E., Benavente, F., Barbosa, J., Sanz-Nebot, V., Classification of congenital disorders of glycosylation based on analysis of transferrin glycopeptides by capillary liquid chromatography-mass spectrometry. Talanta 2016, 160, 614-623.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>del Castillo Busto, M. E., Meija, J., Montes-Bay\xc3\xb3n, M., Sanz-Medel, A., Diophantine analysis complements electrospray-Q-TOF data fur structure elucidation of transferrin glycoforms used in clinical diagnosis in human and cerebrospinal fluid. Proteomics 2009, 9, 1109-1113.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>del Castillo Busto, M. E., Montes-Bay\xc3\xb3n, M., Blanco-Gonz\xc3\xa1lez, E., Meija, J., Sanz-Medel, A., Strategies to study human serum transferrin isoforms using integrated liquid chromatography ICPMS, MALDI-TOF, and ESI-Q-TOF detection: Application to chronic alcohol abuse. Anal. Chem. 2005, 77, 5615-5621.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Sturiale, L., Barone, R., Fiumara, A., Perez, M., Zaffanello, M., Sorge, G., Pavone, L., Tortorelli, S., O`Brien, J. F., Jeaken, J., Garozzo, D., Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia. Glycobiology 2005, 15, 1268-1276.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Landberg, E., Astrom, E., Kagedal, B., Pahlsson, P., Disialo-trisialo bridging of transferrin is due to increased branching and fucosylation of the carbohydrate moiety. Clin. Chim. Acta 2012, 414, 58-64.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Oberrauch, W., Bergman, A.-C., Helander, A., HPLC and mass spectrometric characterization of a candidate reference material for the alcohol biomarker carbohydrate-deficient transferrin (CDT). Clin. Chim. Acta 2008, 395, 142-145.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Quintana, E., Montero, R., Casado, M., Navarro-Sastre, A., Vilaseca, M. A., Briones, P., Artuch, R., Comparison between high performance liquid chromatography and capillary zone electrophoresis for the diagnosis of congenital disorders of glycosylation. J. Chromatogr. B 2009, 877, 2513-2518.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Casado, M., O\'Callaghan, M. M., Montero, R., P\xc3\xa9rez-Cerda, C., P\xc3\xa9rez, B., Briones, P., Quintana, E., Muchart, J., Aracil, A., Pineda, M., Artuch, R., Mild clinical and biochemical phenotype in two patients with PMM2-CDG (congenital disorder of Glycosylation Ia). Cerebellum 2012, 11, 557-563.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Parente, F., Ah Mew, N., Jaeken, J., Gilfix, B. M., A new capillary zone electrophoresis method for the screening of congenital disorders of glycosylation (CDG). Clin. Chim. Acta 2010, 411, 64-66.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Dave, M. B., Dherai, A. J., Udani, V. P., Hegde, A. U., Desai, N. U., Ashavaid, T. F., Comparison of transferrin isoform analysis by capillary electrophoresis and HPLC for screening congential disorders of glycosylation. J. Clin. Lab. Anal. 2017, e22167, 1-8.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Iourin, O., Mattu, T. S., Mian, N., Keir, G., Winchester, B., Dwek, R. A., Rudd, P. M., The identification of abnormal glycoforms of serum transferrin in carbohydrate deficient glycoprotein syndrome type I by capillary zone electrophoresis. Glycoconj. J. 1996, 13, 1031-1042.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Oda, R. P., Prasad, R., Stout, R. L., Coffin, D., Patton, W. P., Kraft, D. L., O\'Brien, J. F., Landers, J. P., Capillary electrophoresis-based separation of transferrin sialoforms in patients with carbohydrate-deficient glycoprotein syndrome. Electrophoresis 1997, 18, 1819-1826.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Sanz-Nebot, V., Gonz\xc3\xa1lez, P., Toro, I., Ribes, A., Barbosa, J., Characterization of human transferrin glycoforms by capillary electrophoresis and electrospray ionization mass spectrometry. J. Chromatogr. B 2003, 798, 1-7.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Tegtmeyer, L. C., Rust, S., van Scherpenzeel, M., Ng, B. G., Losfeld, M.-E., Timal, S., Raymond, K., He, P., Ichikawa, M., Veltman, J., Huijben, K., Shin, Y. S., Sharma, V., Adamowicz, M., Lammens, M., Reunert, J., Witten, A., Schrapers, E., Matthijs, G., Jaeken, J., Rymen, D., Stojkovic, T., Lafor\xc3\xaat, P., Petit, F., Auma\xc3\xaetre, O., Czarnowska, E., Piraud, M., Podskarbi, T., Stanley, C. A., Matalon, R., Burda, P., Seyyedi, S., Debus, V., Socha, P., Sykut-Cegielska, J., van Spronsen, F., de Meirleir, L., Vajro, P., DeClue, T., Ficicioglu, C., Wada, Y., Wevers, R. A., Vanderschaeghe, D., Callewaert, N., Fingerhut, R., Schaftingen, E., Freeze, H. H., Morava, E., Lefeber, D. J., Marquardt, T., Multiple phenotypes in phosphoglucomutase 1 deficiency. N. Engl. J. Med. 2014, 370, 533-542.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Thorn, J., Guillemin, H., de l\'Escaille, F., Quantifying carbohydrate-deficient transferrin in serum. J. Med. Biochem. 2009, 28, 305-308.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Helander, A., Bergstr\xc3\xb6m, J., Freeze, H. H., Testing for congenital disorders of glycosylation by HPLC measurement of serum transferrin Glycoforms. Clin. Chem. 2004, 50, 954-957.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Trout, A. L., Prasad, R., Coffin, D., DiMartini, A., Lane, T., Blessum, C., Khatter, N., Landers, J. P., Direct capillary electrophoretic detection of carbohydrate-deficient transferrin in neat serum. Electrophoresis 2000, 21, 2376-2383.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Strauss, K. A., O\'Kane, J., Cook, J. D., Novel comparison of capillary electrophoresis versus immunoassay in the measurement of total percent carbohydrate deficient transferrin. Clin. Biochem. 2006, 39, 826-832.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Tarentino, A. L., Plummer, T. H., Enzymatic deglycosylation of asparagine-linked glycans: Purification, properties, and specificity of oligosaccharide-cleaving enzymes from Flavobacterium meningosepticum. Meth. Enzymol. 1994, 230, 44-57.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>G\xc3\xb6r\xc3\xb6gh, T., Rudolph, P., Meyer, J. E., Werner, J. A., Lippert, B. M., Maune, S., Separation of \xce\xb2-2-transferrin by denaturing gel electrophoresis to detect cerebrospinal fluid in ear and nasal fluids. Clin. Chem. 2005, 51, 1704-1710.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Rodr\xc3\xadguez-Capote, K., Turner, J., Macri, J., Evaluation of a commercially available carbohydrate deficient transferrin kit to detect beta-2-transferrin in cerebrospinal fluid using capillary electrophoresis. Clin. Biochem. 2013, 46, 1770-1773.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Kwon, S.-J., Zhang, F., Dordick, J. S., Sonstein, W. J., Linhardt, R. J., Detection of cerebrospinal fluid leakage by specific measurement of transferrin glycoforms. Electrophoresis 2015, 36, 2425-2432.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Brown, K. J., Vanderver, A., Hoffman, E. P., Schiffmann, R., Hathout, Y., Characterization of transferrin glycopeptide structures in human cerebrospinal fluid. Int. J. Mass Spectrom. 2012, 312, 97-106.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Hoshi, K., Matsumoto, Y., Ito, H., Saito, K., Honda, T., Yamaguchi, Y., Hashimoto, Y., A unique glycan-isoform of transferrin in cerebrospinal fluid: A potential diagnostic marker for neurological diseases. Biochim. Biophys. Acta Gen. Subj. 2017, 1861, 2473-2478.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Murakami, Y., Matsumoto, Y., Hoshi, K., Ito, H., Fuwa, T. J., Yamaguchi, Y., Nakajiama, M., Miyajima, M., Arai, H., Nollet, K., Kato, N., Nishikata, R., Kuroda, N., Honda, T., Sakuma, J., Saito, K., Hashimoto, Y., Rapid increase of brain-type transferrin in cerebrospinal fluid after shunt surgery for idiopathic normal pressure hydrocephalus: A prognosis marker for cognitive recovery. J. Biochem. 2018, 164, 205-213.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Murakami, Y., Saito, K., Ito, H., Hashimoto, Y., Transferrin isoforms in cerebrospinal fluid and their relation to neurological diseases. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2019, 95, 198-210.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>de Loos, F., Huijben, K. M. L. C., van der Kar, N. C. A. J., Monnens, L. A. H., van den Heuvel, L. P. W. J., Groener, J. E. M., de Moor, R. A., Wevers, R. A., Hemolytic uremic syndrome attributable to Streptococcus pneumoniae infection: A novel cause for secondary protein N-glycan abnormalities, Clin. Chem. 2002, 48, 781-784.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Charlwood, J., Clayton, P., Keir, G., Mian, N., Winchester, B., Defective galactosylation of serum transferrin in galactosemia. Glycobiology 1998, 8, 351-357.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Pronicka, E., Adamowicz, M., Kowalik, A., Ploska, R., Radomyska, B., Rogaszewska, M., Rokicki, D., Sykut-Cegielska, J., Elevated carbohydrate-deficient transferrin (CDT) and its normalization on dietary treatment as a useful biochemical test for hereditary fructose intolerance and galactosemia. Pediatr. Res. 2007, 62, 101-105.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Arndt, T., van der Meijden, B. B., Wielders, J. P. M., Atypical serum transferrin isoform distribution in liver cirrhosis studied by HPLC, capillary electrophoresis and transferrin genotyping. Clin. Chim. Acta 2008, 394, 42-46.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Yang, H.-S., Cho, S. Y., Disialo-trisialo bridging phenomenon of transferrin isoform detected by capillary electrophoresis in patient with alcoholic liver cirrhosis: First case report from Asia. Clin. Lab. 2017, 63, 625-627.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Gonzalo, P., Pecquet, M., Bon, C., Gonzalo, S., Radenne, S., Augustin-Normand, C., Souquet, J.-C., Clinical performance of the carbohydrate-deficient transferrin (CDT) assay by the Sebia Capillarys2 system in case of cirrhosis. Interest of the Bio-Rad%CDT by HPLC test and Siemens N-Latex CDT kit as putative confirmatory methods. Clin. Chim. Acta 2012, 413, 712-718.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Gressner, O. A., Jafari, S., Erkens, M., Gao, C., Stanzel, S., Gressner, A. M., Evaluation of serum percent trisialotransferrin as potential predictive biomarker of hepatocellular dedifferentiation in chronic liver disease. Clin. Chim. Acta 2009, 403, 188-193.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Arndt, T., Erkens, M., Holtkamp, K., Keller, T., Gressner, A. M., High prevalence of increased trisialotransferrin concentrations in patients with anorexia nervosa: Implications for determination of carbohydrate-deficient transferrin. Clin. Chim. Acta 2007, 379, 150-153.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Gudowska, M., Gruszewska, E., Wrona, A., Gindzienska-Sieskiewicz, E., Domyslawska, I., Lipartowska-Klimuk, K., Cylwik, B., Sierakowski, S., Chrostek, L., The profile of serum transferrin isoforms in rheumatoid arthristis. J. Clin. Rheumatol. 2019, 25, 159-162.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Bubel, S., Peters, V., Klein, C., Hackler, R., Schaefer, J. R., Hagenah, J., Hoffmann, G. F., Vieregge, P., CDG (congenital disorders of glycosylation). Zur Differetialdiagnose heredit\xc3\xa4rer Ataxien im Erwachsenenalter. Nervenarzt 2002, 73, 754-760.</Citation>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'